1. Irbesartan in Marfan syndrome (AIMS): a double-blind, placebo-controlled randomised trial. Issue 10216 (21st December 2019) Authors: Mullen, Michael; Jin, Xu Yu; Child, Anne; Stuart, A Graham; Dodd, Matthew; Aragon-Martin, José Antonio; Gaze, David; Kiotsekoglou, Anatoli; Yuan, Li; Hu, Jiangting; Foley, Claire; Van Dyck, Laura; Knight, Rosemary; Clayton, Tim; Swan, Lorna; Thomson, John D R; Erdem, Guliz; Crossman, David; Flath... Journal: Lancet Issue: Volume 394:Issue 10216(2019) Page Start: 2263 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗